Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.54 |
| ▸ | RELA | Q04206 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 2/20 | 0.49 |
| ▸ | CASP1 | P29466 | 1/20 | 0.47 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.47 |
| ▸ | GSK3A | P49840 | 1/20 | 0.47 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.47 |
| ▸ | HIPK1 | Q86Z02 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4781267 | 0.88 | GAA (0.51) | GAAL3MBTL1CYP1A2CYP2A6MEN1 | |
| SCHEMBL10810921 | 0.87 | CYP1A2 (0.49) | GAAL3MBTL1CYP1A2CYP2A6MEN1 | |
| SCHEMBL7419945 | 0.87 | MAOB (0.49) | L3MBTL1NPC1PKMNFKB1RAB9A | |
| SCHEMBL9270474 | 0.87 | MAOB (0.59) | RAB9AMAOBALOX5 | |
| SCHEMBL10411098 | 0.85 | MAOB (0.51) | L3MBTL1NPC1PKMNFKB1RAB9A | |
| SCHEMBL7414630 | 0.85 | CYP4F2 (0.50) | GAAL3MBTL1NPC1PKMNFKB1 | |
| SCHEMBL14258103 | 0.84 | TSHR (0.47) | L3MBTL1SMN1; SMN2CYP1A2CYP2A6MEN1 | |
| SCHEMBL11689706 | 0.84 | AKR1B1 (0.66) | GAAL3MBTL1NPC1PKMNFKB1 | |
| SCHEMBL7639928 | 0.84 | GAA (0.50) | GAAL3MBTL1CYP1A2CYP2A6MEN1 | |
| SCHEMBL1403568 | 0.84 | PTGS1 (0.67) | GAAL3MBTL1NPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12037307-B2 | — | — | 2024-07-16 | — | — | US | disclosed |
| US-12037307-B2 | — | — | 2024-07-16 | — | — | US | disclosed |
| US-20230227400-A1 | HIGH PURITY 2-NAPHTHYLACETONITRILE AND METHOD FOR PRODUCING SAME | API CORPORATION (JP) | 2023-07-20 | — | — | US | disclosed |
| US-20230227400-A1 | HIGH PURITY 2-NAPHTHYLACETONITRILE AND METHOD FOR PRODUCING SAME | API CORPORATION (JP) | 2023-07-20 | — | — | US | disclosed |
| US-11643386-B2 | High purity 2-naphthylacetonitrile and method for producing same | API CORPORATION (JP) | 2023-05-09 | — | — | US | disclosed |
| US-11643386-B2 | High purity 2-naphthylacetonitrile and method for producing same | API CORPORATION (JP) | 2023-05-09 | — | — | US | disclosed |
| CN-114957065-A | Malonic acid dithioester compound, preparation method and application thereof | 沈阳化工大学 | 2022-08-30 | — | — | CN | disclosed |
| EP-3950664-A1 | HIGH PURITY 2-NAPHTHYLACETONITRILE AND METHOD FOR PRODUCING SAME | API Corporation (JP) | 2022-02-09 | — | — | EP | disclosed |
| US-20220009880-A1 | HIGH PURITY 2-NAPHTHYLACETONITRILE AND METHOD FOR PRODUCING SAME | API CORPORATION (JP) | 2022-01-13 | — | — | US | disclosed |
| US-9376417-B2 | Process for preparing aryl- and heteroarylacetic acid derivatives | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2016-06-28 | — | — | US | disclosed |
| EP-0646111-B1 | ARTHROPODICIDAL OXAZOLINES AND THIAZOLINES | DU PONT (US) | 1997-08-20 | — | — | EP | disclosed |
| WO-1997023465-A1 | NEW BARBITURIC ACID DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND PHARMACEUTICAL AGENTS CONTAINING THESE COMPOUNDS | BOEHRINGER MANNHEIM GMBH (DE) | 1997-07-03 | — | — | WO | disclosed |
| US-5633271-A | CONTROLLING ARTHROPODS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1997-05-27 | — | — | US | disclosed |
| EP-0646111-A1 | ARTHROPODICIDAL OXAZOLINES AND THIAZOLINES. | DU PONT (US) | 1995-04-05 | — | — | EP | disclosed |
| WO-1993024470-A1 | ARTHROPODICIDAL OXAZOLINES AND THIAZOLINES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-12-09 | — | — | WO | disclosed |
| US-4642370-A | Process for the production of carboxylic acid esters | THE BRITISH PETROLEUM COMPANY P.L.C. (GB) | 1987-02-10 | — | — | US | disclosed |
| WO-1985000596-A1 | PROCESS FOR THE PRODUCTION OF CARBOXYLIC ACID ESTERS | THE BRITISH PETROLEUM COMPANY P.L.C. (GB) | 1985-02-14 | — | — | WO | disclosed |
| EP-0132144-A1 | Process for the production of carboxylic acid esters | The British Petroleum Company p.l.c. (GB) | 1985-01-23 | — | — | EP | disclosed |
| US-4277490-A | Insecticidal 1-(2-naphthyl)-cyclobutane carboxylate | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANIZATION (AU) | 1981-07-07 | — | — | US | disclosed |
| EP-0003670-A1 | Preparation of alkyl 2-aryl acrylates | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1979-08-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11643386-B2 | High purity 2-naphthylacetonitrile and method for producing same | SULT2A1, GNPAT, SULT1A1 | GAA 334/4885L3MBTL1 4339/4885NPC1 2480/4885 |
| US-20220009880-A1 | HIGH PURITY 2-NAPHTHYLACETONITRILE AND METHOD FOR PRODUCING SAME | SULT2A1, GNPAT, SULT1A1 | GAA 334/4885L3MBTL1 4339/4885NPC1 2480/4885 |
| US-12037307-B2 | — | SULT2A1, SULT1A1, GNPAT | GAA 294/4885L3MBTL1 4471/4885NPC1 2011/4885 |
| US-20230227400-A1 | HIGH PURITY 2-NAPHTHYLACETONITRILE AND METHOD FOR PRODUCING SAME | NAT1, CYP2J2, NQO1 | GAA 445/4885L3MBTL1 4687/4885NPC1 482/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.